Cargando…

Research Progress of DUB Enzyme in Hepatocellular Carcinoma

According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer death worldwide. Although there have been great ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jie, Guo, Jinhui, Wang, Yanan, Ma, Qiancheng, Shi, Yu, Cheng, Feng, Lu, Qiliang, Fu, Wen, Ouyang, Guangxiong, Zhang, Ji, Xu, Qiuran, Hu, Xiaoge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303014/ https://www.ncbi.nlm.nih.gov/pubmed/35875077 http://dx.doi.org/10.3389/fonc.2022.920287

Ejemplares similares

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
por: Lei, Xiangxiang, et al.
Publicado: (2023)

Case Report: Retroperitoneal Sarcoma in Six Operations: Our Experience in Operative Management of Blood Vessels
por: Guo, Jinhui, et al.
Publicado: (2022)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
por: Ma, Qiancheng, et al.
Publicado: (2023)

DUBs, New Members in the Hypoxia Signaling clUb
por: Schober, Amelie S., et al.
Publicado: (2016)

Evaluating enzyme activities and structures of DUBs
por: Pruneda, Jonathan N., et al.
Publicado: (2019)

Dubbing
por: Sibthorpe, Charles
Publicado: (1880)

LncRNA ALKBH3‐AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion
por: Lu, Qiliang, et al.
Publicado: (2022)

Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment
por: Song, Jianning, et al.
Publicado: (2022)

Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis
por: Ohanna, Mickael, et al.
Publicado: (2022)

DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma
por: Jia, Xuebing, et al.
Publicado: (2022)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response
por: Snyder, Nathan A., et al.
Publicado: (2021)

Dubbing: / An analysis of idiomatic expressions in "Coco".
por: Tolentino Cruz, Ana María
Publicado: (2018)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

DUB-independent regulation of pVHL by OTUD6B suppresses hepatocellular carcinoma
por: Dai, Xiaoming, et al.
Publicado: (2020)

Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis
por: Wang, Chunling, et al.
Publicado: (2022)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023)

Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death
por: Chen, Jinghong, et al.
Publicado: (2020)

Survey of the Phosphorylation Status of the Schizosaccharomyces pombe Deubiquitinating Enzyme (DUB) Family
por: McLean, Janel R., et al.
Publicado: (2010)

The emerging roles of deubiquitylating enzymes (DUBs) in the TGFβ and BMP pathways
por: Herhaus, Lina, et al.
Publicado: (2014)

Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
por: Ruan, Jing, et al.
Publicado: (2020)

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3
por: Zhang, Yuanping, et al.
Publicado: (2022)

MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib
por: Guo, Jinhui, et al.
Publicado: (2023)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis
por: Liu, Yang, et al.
Publicado: (2021)

The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
por: Khan, Suliman, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications
por: Hu, Xiaoge, et al.
Publicado: (2018)

Dubbing versus Subtitling: Study on people's preferences/
por: Cázares Castro Miryam Carolina
Publicado: (2014)

Prospects of Noncoding RNAs in Hepatocellular Carcinoma
por: Zhou, Huaixiang, et al.
Publicado: (2018)

A systematic review of progress on hepatocellular carcinoma research over the past 30 years: a machine-learning-based bibliometric analysis
por: Lee, Kiseong, et al.
Publicado: (2023)

Ruptured Hepatocellular Carcinoma: Current Status of Research
por: Xia, Feng, et al.
Publicado: (2022)

Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells
por: Vogel, Rachel Isaksson, et al.
Publicado: (2015)

The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review
por: Yang, Guang-Fei, et al.
Publicado: (2021)

Targeting Deubiquitinating Enzymes (DUBs) That Regulate Mitophagy via Direct or Indirect Interaction with Parkin
por: Tsefou, Eliona, et al.
Publicado: (2022)

Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
por: Zhang, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rb6g19ua2u309mesvb0uhq3m11